组织工程和生物材料为基础的再生医疗市场，规模，占有率，趋势，产业分析报告:各用途，各地区，2025年～2034年的市场预测

根据 Polaris Market Research 的最新研究，预计到 2034 年，组织工程和基于生物材料的再生医学市场规模将达到 88.7948 亿美元。本研究报告深入分析了当前的市场动态，并分析了未来的市场成长。

再生医学已被证明是治疗慢性疾病和临床疾病的有效选择。近年来，组织工程和再生医学取得了显着发展，并正在经历快速变革。组织工程目前被认为是一种透过结合支架、细胞和生物活性分子来治疗器官相关健康问题的有效工具。

个人化医疗的发展推动了对可针对每位患者进行个人化客製化的再生疗法的需求。利用患者自身细胞培育组织和器官可显着降低排斥风险，并改善癒合效果。如今，先进的生物材料可以根据个体的机械和生物需求进行工程设计，从而提高治疗效果。精准医疗的趋势与组织工程的核心竞争力完美契合，并正在推动其发展。

全球捐赠器官和组织的短缺，迫切需要找到替代方案。组织工程提供了一种极具前景的解决方案，它能够利用患者自身细胞在实验室中培育组织和器官，从而降低排斥风险并减少漫长的等待时间。基于生物材料的支架可支持细胞生长和组织形成，为移植手术的成功奠定了基础。随着移植供需缺口的不断扩大，对再生医学技术的需求变得更加迫切，刺激了市场的成长。

组织工程与以生物材料为基础的再生医学市场报告重点

受全球人口中骨骼、关节和软骨相关疾病高发生率的推动，预计肌肉骨骼系统领域在预测期内的复合年增长率将达到 31.5%。

受全球慢性肾病和肾衰竭发病率上升的推动，肾臟病学领域预计将占相当大的市场占有率。

得益于先进的医疗基础设施、强大的研究生态系统和大量的医疗支出，预计北美将在 2024 年主导组织工程和基于生物材料的再生医学市场，占全球收入的 55.80%。

受医疗保健需求成长、医疗基础设施快速发展以及生物技术研究投资增加的推动，预计预测期内亚太市场复合年增长率将达到 32.3%。

全球组织工程和基于生物材料的再生医学市场的主要公司包括 Aspect Biosystems Ltd.、Histogenics Corporation、MiMedx Group, Inc.、Organovo Holdings Inc.、Osiris Therapeutics, Inc.、Takara Bio Inc.、Tissue Regenix Group plc 和 Vericel Corporation。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 组织工程和生物材料为基础的再生医疗市场洞察

• 组织工程和生物材料为基础的再生医疗- 产业概述
• 组织工程和生物材料为基础的再生医疗市场动态
  • 促进因素和机会
    • 全球投资不断增加
    • 2024 年主要资助计画范例
    • 全球资助类型（按年份）
    • 不断扩展的全球临床格局
    • 支架技术的进步
    • 不断成长的需求重建外科和组织工程
    • 重建外科和组织工程的需求不断增长
  • 阻碍与课题
    • 成本相对较高
    • 产生数据的差异
    • 无支架技术的兴起
• PEST 分析
• COVID-19 影响分析
• 产业趋势

第5章 组织工程和生物材料为基础的再生医疗市场评估:各用途

• 简介
• 肌肉骨骼
• 肾臟
• 肝臟

第6章 组织工程和生物材料为基础的再生医疗市场评估:各地区

• 简介
• 北美
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
• 亚太地区
  • 中国
  • 日本
  • 韩国
• 南美
• 中东·非洲

第7章 企业简介

• Organovo Holdings Inc.
• Tissue Regenix Group plc
• Histogenics Corporation
• Aspect Biosystems Ltd.
• Vericel Corporation
• MiMedx Group, Inc.
• Takara Bio Inc.
• Osiris Therapeutics, Inc

第8章 客制化

• 组织工程市场上主要应用的大体的市场占有率

The tissue engineering and biomaterial-based regenerative medicine market size is expected to reach USD 8,879.48 million by 2034, according to a new study by Polaris Market Research. The report "Tissue Engineering and Biomaterial-Based Regenerative Medicine Market Size, Share, Trends, Industry Analysis Report By Application (Musculoskeletal, Kidney, Liver), By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Regenerative medicine is proving to be a valuable treatment option for chronic and clinical medical conditions. Tissue engineering and regenerative medicine have greatly evolved in the recent past and have undergone rapid changes. Tissue engineering is now being considered as an effective tool to treat organ related health issues, through the combination of scaffolds, cells, and biologically active molecules.

The move toward personalized healthcare is driving demand for regenerative treatments that can be customized to individual patients. Using a patient's own cells to grow tissues or organs significantly reduces the chances of rejection and improves healing outcomes. Advanced biomaterials can now be engineered to match the mechanical and biological needs of each person, making treatments more effective. This trend toward precision medicine is aligning perfectly with the core capabilities of tissue engineering, thereby driving the growth.

The global shortage of donor organs and tissues has led to an urgent search for alternatives. Tissue engineering offers a promising solution by enabling the development of lab-grown tissues and organs using the patient's own cells. This reduces the risks of rejection and long waiting times. Biomaterial-based scaffolds help support cell growth and tissue formation, providing a foundation for successful transplants. The need for regenerative medicine technologies becomes even more critical as the gap between supply and demand for transplants continues to widen, fueling market growth.

Tissue Engineering and Biomaterial-Based Regenerative Medicine Market Report Highlights

The musculoskeletal segment is anticipated to register a CAGR of 31.5% during the forecast period, driven by the high prevalence of bone, joint, and cartilage-related disorders across the global population.

The kidney segment is expected to hold a notable share of the market, supported by the rising incidence of chronic kidney disease and kidney failure worldwide.

North America dominated the tissue engineering and biomaterial-based regenerative medicine market in 2024, accounting for 55.80% of the global revenue, fueled by its advanced healthcare infrastructure, strong research ecosystem, and substantial healthcare expenditures.

The Asia Pacific market is projected to register a CAGR of 32.3% during the forecast period, driven by increasing healthcare demand, rapid development of medical infrastructure, and rising investment in biotechnology research.

A few key players in the global tissue engineering and biomaterial-based regenerative medicine market are Aspect Biosystems Ltd.; Histogenics Corporation; MiMedx Group, Inc.; Organovo Holdings Inc.; Osiris Therapeutics, Inc.; Takara Bio Inc.; Tissue Regenix Group plc; and Vericel Corporation.

Polaris Market Research has segmented the tissue engineering and biomaterial-based regenerative medicine market report based on application and region:

By Application (Revenue - USD Million, 2020-2034)

Musculoskeletal

Kidney

Liver

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

Chapter 1. Introduction

• 1.1 Report Description
  • 1.1.1 Objectives of the Study
  • 1.1.2 Market Scope
  • 1.1.3 Assumptions
• 1.2 Stakeholders

Chapter 2. Executive Summary

• 2.1 Market Highlights

Chapter 3. Research Methodology

• 3.1 Overview
  • 3.1.1 Data Mining
• 3.2 Data Sources
  • 3.2.1 Primary Sources
  • 3.2.2 Secondary Sources

Chapter 4. Tissue Engineering and Biomaterial-Based Regenerative Medicine Market Insights

• 4.1 Tissue Engineering and Biomaterial-Based Regenerative Medicine - Industry snapshot
• 4.2 Tissue Engineering and Biomaterial-Based Regenerative Medicine Market Dynamics
  • 4.2.1 Drivers and Opportunities
    • 4.2.1.1 Rising Investments across the globe
    • 4.2.1.1.1 Examples of key financing initiatives, 2024
    • 4.2.1.1.2 Total Global Financings Type by Year
    • 4.2.1.2 Widening Global Clinical Landscape
    • 4.2.1.3 Technological advancements in scaffold technology
    • 4.2.1.4 Increasing demand for body reconstruction procedures and tissue engineering
    • 4.2.1.5 Increasing demand for body reconstruction procedures and tissue engineering
  • 4.2.2 Restraints and Challenges
    • 4.2.2.1 Comparatively High Cost
    • 4.2.2.2 Inconsistency in data generated
    • 4.2.2.3 Advent of scaffold-free technology
• 4.3 Porter's Five Forces Analysis
  • 4.3.1 Bargaining Power of Suppliers (High)
  • 4.3.2 Threats of New Entrants: (Low)
  • 4.3.3 Bargaining Power of Buyers (Moderate)
  • 4.3.4 Threat of Substitute (Moderate)
  • 4.3.5 Rivalry among existing firms (Moderate)
• 4.4 PEST Analysis
• 4.5 Tissue Engineering and Biomaterial-Based Regenerative Medicine Market - Covid Impact Analysis
• 4.6 Tissue Engineering and Biomaterial-Based Regenerative Medicine Market - Industry Trends

Chapter 5. Tissue Engineering and Biomaterial-based Regenerative Medicine Market Assessment by Application

• 5.1 Introduction
• 5.2 Musculoskeletal
• 5.3 Kidney
• 5.4 Liver

Chapter 6. Tissue Engineering and Biomaterial-based Regenerative Medicine Market Assessment by Geography

• 6.1 Introduction
• 6.2 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - North America
  • 6.2.1 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - U.S.
  • 6.2.2 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - Canada
• 6.3 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - Europe
  • 6.3.1 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - Germany
  • 6.3.2 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - UK
  • 6.3.3 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - France
  • 6.3.4 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - Italy
• 6.4 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - Asia Pacific
  • 6.4.1 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - China
  • 6.4.2 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - Japan
  • 6.4.3 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - South Korea
• 6.5 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - Latin America
• 6.6 Tissue Engineering and Biomaterial-based Regenerative Medicine Market - Middle East & Africa

Chapter 7. Company Profiles

• 7.1 Organovo Holdings Inc.
  • 7.1.1 Business Overview
  • 7.1.2 Financial Snapshot
  • 7.1.3 Products and Services
  • 7.1.4 Strategic Initiatives
• 7.2 Tissue Regenix Group plc
  • 7.2.1 Business Overview
  • 7.2.2 Financial Snapshot
  • 7.2.3 Products and Services
• 7.3 Histogenics Corporation
  • 7.3.1 Business Overview
  • 7.3.2 Products and Services
• 7.4 Aspect Biosystems Ltd.
  • 7.4.1 Business Overview
  • 7.4.2 Products and Services
  • 7.4.3 Strategic Initiatives
• 7.5 Vericel Corporation
  • 7.5.1 Business Overview
  • 7.5.2 Financial Snapshot
  • 7.5.3 Products and Services
  • 7.5.4 Strategic Initiatives
• 7.6 MiMedx Group, Inc.
  • 7.6.1 Business Overview
  • 7.6.2 Financial Snapshot
  • 7.6.3 Products and Services
  • 7.6.4 Strategic Initiatives
• 7.7 Takara Bio Inc.
  • 7.7.1 Business Overview
  • 7.7.2 Financial Snapshot
  • 7.7.3 Products and Services
  • 7.7.4 Strategic Initiatives
• 7.8 Osiris Therapeutics, Inc
  • 7.8.1 Business Overview
  • 7.8.2 Products and Services
  • 7.8.3 Strategic Initiatives

Chapter 8. Customization

• 8.1 Approximate Market Share of Major Applications in Tissue Engineering Market

List of Tables

• Table 1 Global Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 2 Global Tissue Engineering and Biomaterial-based Regenerative Medicine Market, by Musculoskeletal Applications, by Region, 2020 - 2034 (USD Million)
• Table 3 Global Tissue Engineering and Biomaterial-based Regenerative Medicine Market, by Kidney Applications, by Region, 2020 - 2034 (USD Million)
• Table 4 Global Tissue Engineering and Biomaterial-based Regenerative Medicine Market, by Liver Applications, by Region, 2020 - 2034 (USD Million)
• Table 5 Tissue Engineering and Biomaterial-based Regenerative Medicine Market Assessment, By Geography, 2020 - 2034 (USD Million)
• Table 6 North America: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 7 North America: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 8 U.S.: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 9 U.S.: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 10 Canada: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 11 Canada: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 12 Europe: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 13 Europe: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 14 Germany: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 15 Germany: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 16 UK: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 17 UK: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 18 France: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 19 France: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 20 Italy: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 21 Italy: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 22 Asia Pacific: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 23 Asia Pacific: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 24 China: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 25 China: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 26 Japan: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 27 Japan: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 28 South Korea: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 29 South Korea: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 30 Latin America: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 31 Latin America: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 32 Middle East & Africa: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, 2020 - 2034 (USD Million)
• Table 33 Middle East & Africa: Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2020 - 2034 (USD Million)
• Table 34 Approximate Global Market Share of Major Applications in Tissue Engineering and Biomaterial-Based Regenerative Medicine Market, 2024, (%)

List of Figures

• Figure 1. Market Highlights
• Figure 2. Research Methodology: Top Down & Bottom Up Approach
• Figure 3. Market by Geography, 2024 & 2034 (USD Million)
• Figure 4. Global Corporate Partnerships, 2020 - 2034 (USD Million)
• Figure 5. Global Venture Capital Initiatives, 2020 - 2034 (USD Million)
• Figure 6. Global IPOs Initiatives, 2020 - 2034 (USD Million)
• Figure 7. Global Follow-On Financings, 2020 - 2034 (USD Million)
• Figure 8. Global Mergers & Acquisitions (Upfront Payment), 2020 - 2034 (USD Million)
• Figure 9. Total Clinical Trials Underway in 2024
• Figure 10. Porter's Five Forces
• Figure 11. Market by Application
• Figure 12. Global Tissue Engineering and Biomaterial-based Regenerative Medicine Market, By Application, 2024 & 2034 (% of total market)
• Figure 13. Tissue Engineering and Biomaterial-based Regenerative Medicine Market Assessment, By Geography, 2024 & 2034 (USD Million)